Qube Research & Technologies Ltd - COMPASS THERAPEUTICS INC ownership

COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 77 filers reported holding COMPASS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of COMPASS THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$531,780
+67.8%
162,624
+158.2%
0.00%0.0%
Q4 2022$316,865
+340.1%
62,995
+19.2%
0.00%
+100.0%
Q1 2022$72,000
-21.7%
52,842
+81.9%
0.00%0.0%
Q4 2021$92,00029,0530.00%
Other shareholders
COMPASS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 914,630$2,908,5233.52%
Foresite Capital Management V, LLC 1,324,071$4,210,5463.08%
CHI Advisors LLC 2,829,712$8,998,4842.73%
Monashee Investment Management LLC 1,969,296$6,262,3611.50%
Orbimed Advisors 22,362,850$71,113,8631.29%
Prosight Management, LP 2,167,994$6,894,2201.03%
Vivo Capital, LLC 3,556,023$11,308,1530.78%
BRAIDWELL LP 5,954,273$18,934,5880.62%
Rock Springs Capital Management LP 5,513,788$17,533,8460.42%
CAXTON CORP 43,466$138,2200.40%
View complete list of COMPASS THERAPEUTICS INC shareholders